Clinical Trials

A brighter future

Our mission is to advance medicines that will provide a brighter future for patients with serious conditions that are not fully served by existing treatments. Our ability to evaluate the safety and efficacy of new therapies is a fundamental part of the development process. We rely on volunteers to enroll in our studies and are very grateful for their participation.
man on hill sunset
doctors looking at brain scans

MAGIC-G1 Clinical Trial for patients suffering with recurrent glioblastoma

Currently open for recruitment at two US hospitals, in North Carolina and Florida, the MAGIC-G1 trial is a phase I study investigating the safety of an experimental drug known as MTX110. In the MAGIC-G1 clinical trial, MTX110 is administered directly to the site of the tumor using a technique called convection-enhanced delivery (CED).

Expanded Access Policy

Publications

Stock Information
Share Data
Stock Performance
Analyst Coverage
Advisor & Investor Contacts

Reports & Presentations

Interim & Annual Reports
Presentations
Corporate Governance
Company Information
Leadership
Board of Directors
General Meetings

Media

SEC Filings
News